tiprankstipranks
Hisamitsu Pharmaceutical Co Inc (JP:4530)
:4530
Japanese Market
4530
Hisamitsu Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4530 full AI Analyst Report?

Hisamitsu Pharmaceutical Co (4530) Income Statement

2 Followers

Hisamitsu Pharmaceutical Co Income Statement

Last quarter (Q1 2026), Hisamitsu Pharmaceutical Co's total revenue was ¥34.66B, a decrease of -3.20% from the same quarter last year. In Q1, Hisamitsu Pharmaceutical Co's net income was ¥2.56B. See Hisamitsu Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Feb 26Feb 25Feb 24Feb 23Feb 22
Total Revenue
¥ 163.02B¥ 156.01B¥ 141.71B¥ 128.33B¥ 120.19B
Gross Profit
¥ 96.12B¥ 91.20B¥ 78.97B¥ 72.70B¥ 70.07B
Operating Expenses
¥ 78.20B¥ 72.30B¥ 65.80B¥ 61.10B¥ 60.73B
Depreciation and Amortization
¥ 7.05B¥ 6.33B¥ 5.17B¥ 4.95B¥ 4.32B
EBITDA
¥ 24.97B¥ 35.04B¥ 24.37B¥ 21.08B¥ 17.30B
Operating Income
¥ 17.92B¥ 18.89B¥ 13.17B¥ 11.60B¥ 9.34B
Other Income/Expenses
¥ 5.74B¥ 9.79B¥ 6.02B¥ 4.51B¥ 3.62B
Pretax Income
¥ 23.66B¥ 28.69B¥ 19.18B¥ 16.11B¥ 12.96B
Net Income
¥ 19.16B¥ 21.76B¥ 13.97B¥ 11.74B¥ 9.66B
Per Share Metrics
Basic EPS
¥ 268.55¥ 295.58¥ 181.61¥ 148.00¥ 118.92
Diluted EPS
¥ 268.22¥ 295.15¥ 181.42¥ 147.88¥ 118.84
Weighted Average Shares Outstanding
 71.35M 73.61M 76.92M 79.34M 81.21M
Weighted Average Shares Outstanding (Diluted)
 71.44M 73.72M 77.00M 79.41M 81.27M
Currency in JPY

Hisamitsu Pharmaceutical Co Earnings and Revenue History